Methods of increasing platelet and hematopoietic stem cell...

Details Methods of increasing platelet and hematopoietic stem cell... Methods of increasing platelet and hematopoietic stem cell...

2003-09-18

2011-11-29

Bunner, Bridget E (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S085100, C424S198100, C424S093100, C424S093700, C435S325000, C514S007900, C530S300000

Reexamination Certificate

active

08067367

ABSTRACT:
A method of increasing hematopoietic stem cell production is disclosed. The method includes administering a TPO mimetic compound to a subject. Pharmaceutical compositions including a TPO mimetic compound and a pharmaceutically acceptable carrier are also disclosed.

REFERENCES:
patent: 3654090 (1972-04-01), Wilhelmus et al.
patent: 3940475 (1976-02-01), Gross
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4612132 (1986-09-01), Wollenberg et al.
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4668619 (1987-05-01), Greenquist et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 5141851 (1992-08-01), Brown et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5198424 (1993-03-01), McEver
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5326558 (1994-07-01), Turner et al.
patent: 5338665 (1994-08-01), Schatz et al.
patent: 5358934 (1994-10-01), Borovsky et al.
patent: 5359115 (1994-10-01), Campbell et al.
patent: 5384331 (1995-01-01), Kogan et al.
patent: 5411942 (1995-05-01), Widmer et al.
patent: 5420328 (1995-05-01), Campbell
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5432018 (1995-07-01), Dower et al.
patent: 5639603 (1997-06-01), Dower et al.
patent: 5723286 (1998-03-01), Dower et al.
patent: 5770358 (1998-06-01), Dower et al.
patent: 5869451 (1999-02-01), Dower et al.
patent: 5932546 (1999-08-01), Barrett et al.
patent: 5989833 (1999-11-01), Charon et al.
patent: 6060052 (2000-05-01), Murray et al.
patent: 6083913 (2000-07-01), Dower et al.
patent: 6121238 (2000-09-01), Dower et al.
patent: 6251864 (2001-06-01), Dower et al.
patent: 6465430 (2002-10-01), Dower et al.
patent: 6506362 (2003-01-01), Dower et al.
patent: 6835809 (2004-12-01), Liu et al.
patent: 7091311 (2006-08-01), Dower et al.
patent: 7189827 (2007-03-01), Feige
patent: 7576056 (2009-08-01), MacDonald et al.
patent: 7615533 (2009-11-01), Yurkow et al.
patent: 7723295 (2010-05-01), MacDonald et al.
patent: 2002/0187124 (2002-12-01), Takahashi
patent: 2003/0158116 (2003-08-01), Dower et al.
patent: 2004/0028649 (2004-02-01), Gianni
patent: 2005/0137133 (2005-06-01), MacDonald et al.
patent: 2006/0040866 (2006-02-01), MacDonald et al.
patent: 2006/0058240 (2006-03-01), Dower et al.
patent: 2006/0210542 (2006-09-01), Yurkow et al.
patent: 2007/0148091 (2007-06-01), Dower et al.
patent: 2008/0119384 (2008-05-01), Yurkow et al.
patent: 2009/0214489 (2009-08-01), Dower et al.
patent: 0 450 715 (1991-10-01), None
patent: 0 613 683 (1994-09-01), None
patent: 0 690 127 (1995-01-01), None
patent: 0 668 352 (1995-02-01), None
patent: 0 675 201 (1995-03-01), None
patent: 0 690 127 (1996-01-01), None
patent: 0 783 003 (1997-07-01), None
patent: 2 186 579 (1987-08-01), None
patent: 2 285 446 (1995-07-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 91/07988 (1991-06-01), None
patent: WO 91/07988 (1991-06-01), None
patent: WO 91/08752 (1991-06-01), None
patent: WO 91/08752 (1991-06-01), None
patent: WO 93/25221 (1993-12-01), None
patent: WO 93/25221 (1993-12-01), None
patent: WO 94/17784 (1994-08-01), None
patent: WO-95/05843 (1995-03-01), None
patent: WO 95/11922 (1995-05-01), None
patent: WO 95/11922 (1995-05-01), None
patent: WO 95/18858 (1995-07-01), None
patent: WO 95/18858 (1995-07-01), None
patent: WO 95/21626 (1995-08-01), None
patent: WO 95/21626 (1995-08-01), None
patent: WO 95/21919 (1995-08-01), None
patent: WO 95/21919 (1995-08-01), None
patent: WO 95/21920 (1995-08-01), None
patent: WO 95/21920 (1995-08-01), None
patent: WO 95/28907 (1995-11-01), None
patent: WO 95/28907 (1995-11-01), None
patent: WO-95/34326 (1995-12-01), None
patent: WO-96/14293 (1996-05-01), None
patent: WO 96/17062 (1996-06-01), None
patent: WO 96/17062 (1996-06-01), None
patent: WO 96/ 17062 (1996-06-01), None
patent: WO 96/17067 (1996-06-01), None
patent: WO 96/17067 (1996-06-01), None
patent: WO-96/34016 (1996-10-01), None
patent: WO 96/40189 (1996-12-01), None
patent: WO 96/40750 (1996-12-01), None
patent: WO 98/25965 (1998-06-01), None
patent: WO-9825965 (1998-06-01), None
patent: WO 01/21180 (2001-03-01), None
patent: WO-02/051861 (2002-07-01), None
patent: WO 02/076612 (2002-10-01), None
patent: WO-2004/026332 (2004-04-01), None
patent: WO-2005/023834 (2005-03-01), None
Fibbe et al. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 86(9): 3308-3313, 1995.
Cwirla et al. Peptide agonist of the thrombopoietic receptor as potent as the natural cytokine. Science 276: 1696-1699, 1997.
Dower et al. Peptide agonists of the thrombopoietin receptor. Stem Cells 16(Suppl 2): 21-29, 1998.
Kuter et al. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100(10): 3457-3469, 2002.
Kaushansky et al., “Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoletin”, Nature, vol. 369, pp. 568-571 (1994).
Solar et al., “Role of c-mpl in Early Hematopoiesis”, Blood, vol. 92, pp. 4-10 (1998).
Ku et al., “Thrombopoietin, the Ligand for the Mpl Receptor, Synergizes With Steel Factor and Other Early Acting Cytokines in Supporting Proliferation of Primitive Hematopoletic Progenitors of Mice”, Blood, vol. 87, pp. 4544-4551 (1996).
Sitnicka et al., “The Effect of Thrombopoletin on the Proliferation and Differentiation of Murine Hematopoletic Stem Cells”, Blood, vol. 87, pp. 4998-5005 (1996).
Kimura et al., “Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin”, Proc. Natl. Acad. Sci. U.S.A., vol. 95, pp. 1195-1200 (1998).
Ballmaier et al., “c-mpl mutations are the cause of congenital emegakaryocytic thrombocytopenia”, Blood, vol. 97, pp. 139-146 (2001).
Fox et al., “Thrombopoietin expands hematopoletic stem cells after transplantation”, J. Clin. Invest., vol. 110, pp. 389-394 (2002).
International Search Report dated Mar. 3, 2004 for corresponding Appln. No. PCT/US03/29701.
International Preliminary Examination Report dated Apr. 3, 2006 for corresponding Appln. No. PCT/US03/29701.
Barker et al. “Cyclic RGD Peptide Analogues as Antiplatelet Antithrombotics”, J. Med. Chem. vol. 35, pp. 2040-2048 (1992).
Bartley et al. “Identification and Cloning of a Megakaryocyte Growth and Development Factor That Is a Ligand for the Cytokine Receptor Mpl”, Cell, vol. 77, pp. 1117-1124 (1994).
Basser et al., “Randomized, Blinded, Placebo-Controlled Phase I Trail of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor With Filgrastim After Dose-Intensive Chemotherapy in Patients With Advanced Canter”, Blood, vol. 89, No. 9, pp. 3118-3128 (1997).
Bazan, “Structural design and molecular evolution of a cytokine receptor superfamily”, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6934-6938 (1990).
Berger et al. “A New Method for the Synthesis of Optically Active α-Amino Acids and Their NαDerivativesviaAcylamino Malonates”, J. Org. Chem., vol. 38, No. 3, pp. 457-460 (1973).
Caras et al. “Signal Peptide for Protein Secretion Directing Glycophospholipid Membrane Anchor Attachment”, Science, vol. 243, pp. 1196-1198 (1989).
Cwirla et al. “Peptides on Phage: A Vast Library of Peptides for Identifying Ligands”, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6378-6382 (1990).
Daumas et al. “Gramicidin A analogs: influence of the substitution of the tryptophans by naphthylalanines”, Biochimie, vol. 71, pp. 77-81 (1989).
de Sauvage et al. “Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand”, Nature, vol. 369, pp. 533-538 (1994).
Dexter et al. “Growth of Factor-Dependent Hemopoietic Precursor Cell Lines”, J. Exp. Med., vol. 152, pp. 1036-1047 (1980).
Dower et al. “The Search

Affiliated with

Also associated with

Rating

Methods of increasing platelet and hematopoietic stem cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of increasing platelet and hematopoietic stem cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of increasing platelet and hematopoietic stem cell... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4292572